CTO Realty Growth, Inc. (CTO)
NYSE: CTO · Real-Time Price · USD
16.44
-0.07 (-0.42%)
Aug 1, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $22, which forecasts a 33.82% increase in the stock price over the next year. The lowest target is $21 and the highest is $23.
Price Target: $22.00 (+33.82%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +27.74% | Jul 30, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $24 → $22 | Strong Buy | Maintains | $24 → $22 | +33.82% | May 23, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $23 → $23 | Strong Buy | Reiterates | $23 → $23 | +39.90% | Mar 5, 2025 |
| Jones Trading | Jones Trading | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +33.82% | Feb 25, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $22 → $24 | Buy → Strong Buy | Upgrades | $22 → $24 | +45.99% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
148.19M
from 124.52M
Increased by 19.01%
Revenue Next Year
159.13M
from 148.19M
Increased by 7.38%
EPS This Year
-1.75
from -0.35
EPS Next Year
-1.62
from -1.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 158.8M | 177.3M |
| Avg | 148.2M | 159.1M |
| Low | 140.7M | 145.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 27.5% | 19.6% |
| Avg | 19.0% | 7.4% |
| Low | 13.0% | -1.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.06 | -0.03 |
| Avg | -1.75 | -1.62 |
| Low | -3.07 | -2.51 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.